Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001438133-19-000025)

Filing Details

Accession Number:: 0001438133-19-000025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-26 19:36:57
Reporting Period:: 2019-11-25

Accepted Time:: 2019-11-26 19:36:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365369	F John Sheridan	C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121	President & Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-25	462	$2.59	2,963	No	4	M	Direct
Common Stock	Disposition	2019-11-25	462	$70.00	2,501	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2019-11-25	462	$0.00	462	$2.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,667			No	4	M	Direct

Footnotes

Represents shares of common stock received upon exercise of a stock option award.
The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 6, 2019.
The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.